NPM1 and hematologic disorder: This therapeutic strategy may be also attractive for tackling haematological disorders caused by chromosomal translocations in which the N-terminal region of NPM1 is fused to other proteins, i.e. NPM-ALK, NPM-RARα and NPM-MLF1.